Citations (112)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Stephen Maxwell Montgomery, Luke Green, Hajer Karoui, Richard Nicholas & Jaclyn Loh. (2023) To wait, or too late? Modeling the effects of delayed ofatumumab treatment in relapsing-remitting multiple sclerosis. Journal of Medical Economics 26:1, pages 139-148.
Read now
Read now
Kader Eldemir, Arzu Guclu-Gunduz, Sefa Eldemir, Fettah Saygili, Cagla Ozkul & Ceyla Irkec. (2023) Effects of Pilates-based telerehabilitation on physical performance and quality of life in patients with multiple sclerosis. Disability and Rehabilitation 0:0, pages 1-8.
Read now
Read now
Sandra Aguilar-Zafra, Tamara del Corral, Noelia Montero-González, Almudena de-Gabriel-Hierro & Ibai López-de-Uralde-Villanueva. (2022) Urinary incontinence and impaired physical function are associated with expiratory muscle weakness in patients with multiple sclerosis. Disability and Rehabilitation 44:14, pages 3531-3539.
Read now
Read now
Katherine B. Knox, Lynne Clay, Kiersten Stuart-Kobitz & Darren Nickel. (2020) Perspectives on walking from people with multiple sclerosis and reactions to video self-observation. Disability and Rehabilitation 42:2, pages 211-218.
Read now
Read now
Rafael Arroyo González. (2018) A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis. Expert Review of Neurotherapeutics 18:10, pages 785-791.
Read now
Read now
Susan L. Kasser & Maria Kosma. (2018) Social Cognitive Factors, Physical Activity, and Mobility Impairment in Adults with Multiple Sclerosis. Behavioral Medicine 44:4, pages 306-313.
Read now
Read now
Andrea Stennett, Lorraine De Souza & Meriel Norris. (2018) Physical activity and exercise priorities in community dwelling people with multiple sclerosis: a Delphi study. Disability and Rehabilitation 40:14, pages 1686-1693.
Read now
Read now
Matthew F Sidovar, Brendan L Limone & Craig I Coleman. (2016) Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort. Patient Related Outcome Measures 7, pages 13-18.
Read now
Read now
Jennifer Smrtka, Theodore Brown & Greg Bjorklund. (2016) Loss of mobility and the patient burden of multiple sclerosis: expert opinion on relevance to daily clinical practice. Postgraduate Medicine 128:1, pages 145-151.
Read now
Read now
Susan L. Kasser, Jesse V. Jacobs, Marley Ford & Timothy W. Tourville. (2015) Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation. Disability and Rehabilitation 37:24, pages 2238-2249.
Read now
Read now
Christine G. Kohn, Craig I. Coleman, C. Michael White, Matthew F. Sidovar & Diana M. Sobieraj. (2014) Mobility, walking and physical activity in persons with multiple sclerosis. Current Medical Research and Opinion 30:9, pages 1857-1862.
Read now
Read now
Michael Prugger & Thomas Berger. (2013) Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases. Patient Related Outcome Measures 4, pages 75-85.
Read now
Read now
Herbert R Henney$suffix/text()$suffix/text() & Andrew R Blight. (2012) Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets. Degenerative Neurological and Neuromuscular Disease 2, pages 53-64.
Read now
Read now
Andrea Conrad, Michaela Coenen, Henriette SchmalZ, Jürg Kesselring & Alarcos Cieza. (2012) Validation of the Comprehensive ICF Core Set for Multiple Sclerosis from the perspective of occupational therapists. Scandinavian Journal of Occupational Therapy 19:6, pages 468-487.
Read now
Read now
Sheryl R. Haut, E. Jay Bienen & Aaron Miller. (2012) Clinical overview of the seizure risk of dalfampridine
. Expert Opinion on Drug Safety 11:4, pages 651-657.
Read now
Read now
Keith C Hayes. (2011) Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatric Disease and Treatment 7, pages 229-239.
Read now
Read now
Joshua T Cohen. (2010) Walking speed and economic outcomes for walking-impaired patients with multiple sclerosis. Expert Review of Pharmacoeconomics & Outcomes Research 10:5, pages 595-603.
Read now
Read now
Articles from other publishers (95)
Clara Stein, Fiadhnait O'Keeffe, Orla Strahan, Christopher McGuigan & Jessica Bramham. (2023) Systematic review of cognitive reserve in multiple sclerosis: Accounting for physical disability, fatigue, depression, and anxiety. Multiple Sclerosis and Related Disorders 79, pages 105017.
Crossref
Crossref
Fatih Soke, Fatma Aydin, Selda Karakoc, Cagri Gulsen, Mustafa Ertugrul Yasa, Nursena Ersoy, Elvan Ozcan Gulsen & Canan Yucesan. (2023) Effects of backward walking training on balance, gait, and functional mobility in people with multiple sclerosis: A randomized controlled study. Multiple Sclerosis and Related Disorders 79, pages 104961.
Crossref
Crossref
Laura Byrnes-Blanco, Kyle Reed, Rajiv Dubey & Stephanie L. Carey. (2023) A systematic literature review of ankle-foot orthosis and functional electrical stimulation foot-drop treatments for persons with multiple sclerosis. Prosthetics & Orthotics International 47:4, pages 358-367.
Crossref
Crossref
Ka-Hoo Lam, Ioan Gabriel Bucur, Pim van Oirschot, Frank de Graaf, Eva Strijbis, Bernard Uitdehaag, Tom Heskes, Joep Killestein & Vincent de Groot. (2023) Personalized monitoring of ambulatory function with a smartphone 2-minute walk test in multiple sclerosis. Multiple Sclerosis Journal 29:4-5, pages 606-614.
Crossref
Crossref
Massimiliano Pau, Micaela Porta, Gabriella Spinicci, Jessica Frau, Lorena Lorefice, Giancarlo Coghe & Eleonora Cocco. (2022) Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study. Neurological Sciences 44:2, pages 685-691.
Crossref
Crossref
Herbert Karpatkin, Barbara Siminovich-BlokJaya RachwaniZabrina LangerStephanie Winsor. (2023) Effect of Acupuncture on Sensorimotor Function and Mobility in Patients with Multiple Sclerosis: A Pilot Study. Journal of Integrative and Complementary Medicine 29:1, pages 42-49.
Crossref
Crossref
Thomas Campbell Arnold, Colbey W. Freeman, Brian Litt & Joel M. Stein. (2022) Low‐field MRI: Clinical promise and challenges. Journal of Magnetic Resonance Imaging 57:1, pages 25-44.
Crossref
Crossref
Michael VanNostrand, Brittany Belanger, Gabriel Purin, Susan L. Kasser & Michael Cannizzaro. (2022) Cognitive-Motor Interference and Cortical Activation While Walking in Individuals With Multiple Sclerosis. Motor Control 26:4, pages 677-693.
Crossref
Crossref
Stephanie L. Silveira, Robert W. Motl, David X. Marquez & Amber Salter. (2022) Rates and patterns of physical activity among Hispanics with multiple sclerosis in the NARCOMS Registry. Multiple Sclerosis and Related Disorders 65, pages 104018.
Crossref
Crossref
Hoa H Le, Jennifer Ken-Opurum, Anne LaPrade, Martine C Maculaitis & John J Sheehan. (2022) Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey data. Multiple Sclerosis and Related Disorders 65, pages 103971.
Crossref
Crossref
Björn Zörner, Pascal Hostettler, Christian Meyer, Tim Killeen, Pauline Gut, Michael Linnebank, Michael Weller, Dominik Straumann & Linard Filli. (2022) Prognosis of walking function in multiple sclerosis supported by gait pattern analysis. Multiple Sclerosis and Related Disorders 63, pages 103802.
Crossref
Crossref
Helmut Butzkueven, Tim Spelman, Dana Horakova, Stella Hughes, Claudio Solaro, Guillermo Izquierdo, Eva Kubala Havrdová, Francois Grand'Maison, Alexandre Prat, Marc Girard, Raymond Hupperts, Marco Onofrj, Alessandra Lugaresi, Bruce Taylor, Gavin Giovannoni, Ludwig Kappos, Stephen L. Hauser, Xavier Montalban, Licinio Craveiro, Rita Freitas, Fabian Model, James Overell, Erwan Muros‐Le Rouzic, Annette Sauter, Qing Wang, David Wormser & Jerry S. Wolinsky. (2021) Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry. European Journal of Neurology 29:4, pages 1082-1090.
Crossref
Crossref
Gavin Giovannoni, Ludwig Kappos, Jerome de Seze, Stephen L. Hauser, James Overell, Harold Koendgen, Marianna Manfrini, Qing Wang & Jerry S. Wolinsky. (2021) Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials. European Journal of Neurology 29:4, pages 1238-1242.
Crossref
Crossref
Evelyne Wiskerke, Jan Kool, Roger Hilfiker, Karl Martin Sattelmayer & Geert Verheyden. (2022) Determining the Optimal Virtual Reality Exergame Approach for Balance Therapy in Persons With Neurological Disorders Using a Rasch Analysis: Longitudinal Observational Study. JMIR Serious Games 10:1, pages e30366.
Crossref
Crossref
Phu D. Hoang, Stephen Lord, Simon Gandevia & Jasmine Menant. (2022) Exercise and Sports Science Australia (ESSA) position statement on exercise for people with mild to moderate multiple sclerosis. Journal of Science and Medicine in Sport 25:2, pages 146-154.
Crossref
Crossref
Raymond Hupperts, Claudio Gasperini, Jan Lycke, Tjalf Ziemssen, Peter Feys, Shan Xiao, Carlos Acosta, Thijs Koster & Jeremy Hobart. (2022)
Efficacy of prolonged-release fampridine
versus
placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE
. Therapeutic Advances in Neurological Disorders 15, pages 175628642210903.
Crossref
Crossref
T. Campbell Arnold, Danni Tu, Serhat V. Okar, Govind Nair, Samantha By, Karan D. Kawatra, Timothy E. Robert-Fitzgerald, Lisa M. Desiderio, Matthew K. Schindler, Russell T. Shinohara, Daniel S. Reich & Joel M. Stein. (2022) Sensitivity of portable low-field magnetic resonance imaging for multiple sclerosis lesions. NeuroImage: Clinical 35, pages 103101.
Crossref
Crossref
Samuel F. Hunter, Rany A. Aburashed, Raed Alroughani, Andrew Chan, Dominique Dive, Sara Eichau, Daniel Kantor, Ho Jin Kim, Jan Lycke, Richard A. L. Macdonell, Carlo Pozzilli, Thomas Scott, Basil Sharrack, Heinz Wiendl, Luke Chung, Nadia Daizadeh, Darren P. Baker & Patrick Vermersch. (2021) Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies. Neurology and Therapy 10:2, pages 803-818.
Crossref
Crossref
Alex J. Hope, Utkarsh Vashisth, Matthew J. Parker, Andreas B. Ralston, Joshua M. Roper & John D. Ralston. (2021) Phybrata Sensors and Machine Learning for Enhanced Neurophysiological Diagnosis and Treatment. Sensors 21:21, pages 7417.
Crossref
Crossref
Alexandra C. Fietsam, Warren G. Darling, Jacob J. Sosnoff, Craig D. Workman, John Kamholz & Thorsten Rudroff. (2021) Cerebellar Contributions to Motor Impairments in People with Multiple Sclerosis. The Cerebellum 21:6, pages 1052-1060.
Crossref
Crossref
Stephanie L. Silveira, Trinh Huynh, Ariel Kidwell, Dena Sadeghi-Bahmani & Robert W. Motl. (2021) Behavior Change Techniques in Physical Activity Interventions for Multiple Sclerosis. Archives of Physical Medicine and Rehabilitation 102:9, pages 1788-1800.
Crossref
Crossref
Giovanni Castelnovo, Oliver Gerlach, Mark S. Freedman, Arnfin Bergmann, Vladimiro Sinay, Tamara Castillo-Triviño, George Kong, Thijs Koster, Heather Williams, Arie R. Gafson & Joep Killestein. (2021) Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study. CNS Drugs 35:9, pages 1009-1022.
Crossref
Crossref
Coralie Delahaye, Dorine Chaves, Florian Congnard, Bénédicte Noury-Desvaux & Pierre-Yves de Müllenheim. (2021) Measuring Outdoor Walking Capacities Using Global Positioning System in People with Multiple Sclerosis: Clinical and Methodological Insights from an Exploratory Study. Sensors 21:9, pages 3189.
Crossref
Crossref
Iu.E. Korzhova, I.S. Bakulin, A.G. Poydasheva, A.S. Klochkov, I.V. Zakroyshschikova, N.A. Suponeva, L.Sh. Askarova & M.N. Zakharova. (2021) Rehabilitation of patients with multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:7, pages 13.
Crossref
Crossref
Jerry S Wolinsky, Douglas L Arnold, Bruno Brochet, Hans-Peter Hartung, Xavier Montalban, Robert T Naismith, Marianna Manfrini, James Overell, Harold Koendgen, Annette Sauter, Iain Bennett, Stanislas Hubeaux, Ludwig Kappos & Stephen L Hauser. (2020) Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial. The Lancet Neurology 19:12, pages 998-1009.
Crossref
Crossref
J. Twose, G. Licitra, H. McConchie, K. H. Lam & J. Killestein. (2020) Early-warning signals for disease activity in patients diagnosed with multiple sclerosis based on keystroke dynamics. Chaos: An Interdisciplinary Journal of Nonlinear Science 30:11, pages 113133.
Crossref
Crossref
Eva Costa Arpín. (2020) Efficacy and safety of fampridine for walking disability in multiple sclerosis. Neurodegenerative Disease Management 10:5, pages 277-287.
Crossref
Crossref
Christian Meyer, Tim Killeen, Lilla Lörincz, Armin Curt, Marc Bolliger, Michael Linnebank, Björn Zörner & Linard Filli. (2019) Repeated assessment of key clinical walking measures can induce confounding practice effects. Multiple Sclerosis Journal 26:11, pages 1298-1302.
Crossref
Crossref
Erin M. Edwards, Deborah A. Kegelmeyer, Anne D. Kloos, Manon Nitta, Danya Raza, Deborah S. Nichols-Larsen & Nora E. Fritz. (2020) Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS. Multiple Sclerosis International 2020, pages 1-10.
Crossref
Crossref
Atefeh Basirat, Hadi Raeisi Shahraki, Hamid reza Farpour & Leila Habibi. (2020) The Correlation between Using Social Networks and the General Health of Multiple Sclerosis Patients. Multiple Sclerosis International 2020, pages 1-7.
Crossref
Crossref
Ashley Marie Polhemus, Ronny Bergquist, Magda Bosch de Basea, Gavin Brittain, Sara Catherine Buttery, Nikolaos Chynkiamis, Gloria dalla Costa, Laura Delgado Ortiz, Heleen Demeyer, Kirsten Emmert, Judith Garcia Aymerich, Heiko Gassner, Clint Hansen, Nicholas Hopkinson, Jochen Klucken, Felix Kluge, Sarah Koch, Letizia Leocani, Walter Maetzler, M Encarna Micó-Amigo, A Stefanie Mikolaizak, Paolo Piraino, Francesca Salis, Christian Schlenstedt, Lars Schwickert, Kirsty Scott, Basil Sharrack, Kristin Taraldsen, Thierry Troosters, Beatrix Vereijken, Ioannis Vogiatzis, Alison Yarnall, Claudia Mazza, Clemens Becker, Lynn Rochester, Milo Alan Puhan & Anja Frei. (2020) Walking-related digital mobility outcomes as clinical trial endpoint measures: protocol for a scoping review. BMJ Open 10:7, pages e038704.
Crossref
Crossref
F.E. van der Feen, G.A. de Haan, I. van der Lijn, D.J. Heersema, J.F. Meilof & J. Heutink. (2020) Independent outdoor mobility of persons with multiple sclerosis – A systematic review. Multiple Sclerosis and Related Disorders 37, pages 101463.
Crossref
Crossref
Victoria Wood & Susan L. Kasser. (2020) Spousal support and self-determined physical activity in individuals with multiple sclerosis: A theory-informed qualitative exploration. Disability and Health Journal 13:1, pages 100835.
Crossref
Crossref
Anna Lubkowska, Aleksandra Radecka, Anna Knyszyńska & Joanna Łuczak. (2019) Effect of whole-body cryotherapy treatments on the functional state of patients with MS (multiple sclerosis) in a Timed 25-Foot Walk Test and Hand Grip Strength Test. Pomeranian Journal of Life Sciences 64:4, pages 46-49.
Crossref
Crossref
Linda Miller Renfrew, Anna C. Lord, Jake Warren & Rebecca Hunter. (2019) Evaluating the Effect of Functional Electrical Stimulation Used for Foot Drop on Aspects of Health-Related Quality of Life in People with Multiple Sclerosis. International Journal of MS Care 21:4, pages 173-182.
Crossref
Crossref
Maxime Valet, Thierry Lejeune, Marine Devis, Vincent van Pesch, Souraya El Sankari & Gaëtan Stoquart. (2019) Timed Up-and-Go and 2-Minute Walk Test in patients with multiple sclerosis with mild disability: reliability, responsiveness and link with perceived fatigue. European Journal of Physical and Rehabilitation Medicine 55:4.
Crossref
Crossref
Hilary Gunn, Jackie Andrade, Lorna Paul, Linda Miller, Siobhan Creanor, Kara Stevens, Colin Green, Paul Ewings, Andrew Barton, Margie Berrow, Jane Vickery, Ben Marshall, John Zajicek & Jennifer Freeman. (2019) A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT. Health Technology Assessment 23:27, pages 1-166.
Crossref
Crossref
E. Noseda Grau, G. Román, A. Díaz Compañy, G. Brizuela, A. Juan & S. Simonetti. (2019) Relevance of silica surface morphology in Ampyra adsorption. Insights from quantum chemical calculations. RSC Advances 9:8, pages 4415-4421.
Crossref
Crossref
D. Valadkevičienė, I. Žukauskaitė & D. Jatužis. (2019) Sergančiųjų išsėtine skleroze biopsichosocialinis vertinimas, taikant Tarptautinės funkcionavimo, neįgalumo ir sveikatos klasifikacijos trumpąjį kategorijų rinkinį, ir jo sąsajos su darbingumo lygiu. Neurologijos seminarai 22:77, pages 201-212.
Crossref
Crossref
Jeremy Hobart, Tjalf Ziemssen, Peter Feys, Michael Linnebank, Andrew D. Goodman, Rachel Farrell, Raymond Hupperts, Andrew R. Blight, Veronica Englishby, Manjit McNeill, Ih Chang, Gabriel Lima & Jacob Elkins. (2018) Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine. CNS Drugs 33:1, pages 61-79.
Crossref
Crossref
Feng Yang, Mu Qiao, Xiaogang Su & Joash Lazarus. (2019) Relative importance of physical and psychological factors to slowness in people with mild to moderate multiple sclerosis. Multiple Sclerosis and Related Disorders 27, pages 81-90.
Crossref
Crossref
H. Gunn, J. Andrade, L. Paul, L. Miller, S. Creanor, C. Green, J. Marsden, P. Ewings, M. Berrow, J. Vickery, A. Barton, B. Marshall, J. Zajicek & J. A. Freeman. (2017) Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial. Pilot and Feasibility Studies 4:1.
Crossref
Crossref
Douglas N. Martini, Eline Zeeboer, Andrea Hildebrand, Brett W. Fling, Cinda L. Hugos & Michelle H. Cameron. (2018) ADSTEP: Preliminary Investigation of a Multicomponent Walking Aid Program in People With Multiple Sclerosis. Archives of Physical Medicine and Rehabilitation 99:10, pages 2050-2058.
Crossref
Crossref
Hilary Gunn, Michelle Cameron, Phu Hoang, Stephen Lord, Steve Shaw & Jennifer Freeman. (2018) Relationship Between Physiological and Perceived Fall Risk in People With Multiple Sclerosis: Implications for Assessment and Management. Archives of Physical Medicine and Rehabilitation 99:10, pages 2022-2029.
Crossref
Crossref
Linard Filli, Tabea Sutter, Christopher S. Easthope, Tim Killeen, Christian Meyer, Katja Reuter, Lilla Lörincz, Marc Bolliger, Michael Weller, Armin Curt, Dominik Straumann, Michael Linnebank & Björn Zörner. (2018) Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time. Scientific Reports 8:1.
Crossref
Crossref
Philipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, Rachel Farrell, Peter Feys, Jeremy Hobart, Raymond Hupperts, Michael Linnebank, Jožef Magdič, Celia Oreja-Guevara, Carlo Pozzilli, Antonio Vasco Salgado & Tjalf Ziemssen. (2018) Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting. Therapeutic Advances in Neurological Disorders 11, pages 175628641880324.
Crossref
Crossref
Kassem Sharif, Abdulla Watad, Nicola Luigi Bragazzi, Micheal Lichtbroun, Howard Amital & Yehuda Shoenfeld. (2018) Physical activity and autoimmune diseases: Get moving and manage the disease. Autoimmunity Reviews 17:1, pages 53-72.
Crossref
Crossref
Musa Audu, Rudi Kobetic, Stephen Selkirk & Ronald J. Triolo. 2018. Neuromodulation. Neuromodulation
1171
1182
.
Tamsyn Street. (2017) Management of the symptoms of multiple sclerosis using functional electrical stimulation and exercise. Neurodegenerative Disease Management 7:4, pages 253-259.
Crossref
Crossref
Kayla McGowan, Shaila M. Gunn, Galina Vorobeychik & Daniel S. Marigold. (2017) Short-Term Motor Learning and Retention During Visually Guided Walking in Persons With Multiple Sclerosis. Neurorehabilitation and Neural Repair 31:7, pages 648-656.
Crossref
Crossref
Elizabeth L. Yanik, Ruth M. Pfeiffer, D. Michal Freedman, Martin A. Weinstock, Elizabeth K. Cahoon, Sarah T. Arron, Matthew Chaloux, M. Kari Connolly, Priyadharsini Nagarajan & Eric A. Engels. (2017) Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States. Cancer Epidemiology, Biomarkers & Prevention 26:7, pages 998-1007.
Crossref
Crossref
Shmuel Springer & Sam Khamis. (2017) Effects of functional electrical stimulation on gait in people with multiple sclerosis – A systematic review. Multiple Sclerosis and Related Disorders 13, pages 4-12.
Crossref
Crossref
Caspar E. P. van Munster & Bernard M. J. Uitdehaag. (2017) Outcome Measures in Clinical Trials for Multiple Sclerosis. CNS Drugs 31:3, pages 217-236.
Crossref
Crossref
Linard FilliBjörn ZörnerSandra KapitzaKatja ReuterLilla LörinczDavid WellerTabea SutterTim KilleenPhilipp GruberJens A. PetersenMichael WellerMichael Linnebank. (2017) Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis. Neurology 88:9, pages 832-841.
Crossref
Crossref
Sanela Slavković, Milica Tošić & Špela Golubović. (2017) Factors affecting social functioning of persons with multiple sclerosis. Timocki medicinski glasnik 42:4, pages 209-216.
Crossref
Crossref
E. Jones, J. Pike, T. Marshall & X. Ye. (2016) Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US. BMC Health Services Research 16:1.
Crossref
Crossref
J. A. Freeman, W. Hendrie, S. Creanor, L. Jarrett, A. Barton, C. Green, J. Marsden, E. Rogers & J. Zajicek. (2016) Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis. BMC Neurology 16:1.
Crossref
Crossref
Lidwine Brigitta Mokkink, Francisca Galindo-Garre & Bernard MJ Uitdehaag. (2016) Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory. Multiple Sclerosis Journal 22:14, pages 1867-1873.
Crossref
Crossref
Matthew M. Engelhard, Karen M. Schmidt, Casey E. Engel, J. Nicholas Brenton, Stephen D. Patek & Myla D. Goldman. (2016) The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory. Quality of Life Research 25:12, pages 3221-3230.
Crossref
Crossref
Matthew M. Engelhard, Sriram Raju Dandu, Stephen D. Patek, John C. Lach & Myla D. Goldman. (2016) Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjects. Gait & Posture 49, pages 340-345.
Crossref
Crossref
Deborah Backus. (2016) Increasing Physical Activity and Participation in People With Multiple Sclerosis: A Review. Archives of Physical Medicine and Rehabilitation 97:9, pages S210-S217.
Crossref
Crossref
Richard Macdonell, Guy Nagels, David-Axel Laplaud, Carlo Pozzilli, Brigit de Jong, Ana Martins da Silva, Richard Nicholas, Jeannette Lechner-Scott, Julia A Gaebler, Sonalee Agarwal, Ping Wang, Michael Yeh, Maria Hovenden & Per Soelberg Sørensen. (2015) Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine. Multiple Sclerosis Journal 22:7, pages 944-954.
Crossref
Crossref
Raymond Hupperts, Jan Lycke, Christine Short, Claudio Gasperini, Manjit McNeill, Rossella Medori, Agata Tofil-Kaluza, Maria Hovenden, Lahar R Mehta & Jacob Elkins. (2015) Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial. Multiple Sclerosis Journal 22:2, pages 212-221.
Crossref
Crossref
Cecilie Fjeldstad, Gustavo Suárez, Michael Klingler, Herbert R. HenneyIIIIII, Adrian L. Rabinowicz & Gabriel Pardo. (2015) Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis. International Journal of MS Care 17:6, pages 275-283.
Crossref
Crossref
Robert W. Motl, Norman Putzki, Lara A. Pilutti & Diego Cadavid. (2015) Longitudinal Changes in Self-Reported Walking Ability in Multiple Sclerosis. PLOS ONE 10:5, pages e0125002.
Crossref
Crossref
M Kehoe, J Saunders, P Jakeman & S Coote. (2014) Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial. Multiple Sclerosis Journal 21:5, pages 590-598.
Crossref
Crossref
Lori Mayer, Tina Warring, Stephanie Agrella, Helen L. Rogers & Edward J. Fox. (2015) Effects of Functional Electrical Stimulation on Gait Function and Quality of Life for People with Multiple Sclerosis Taking Dalfampridine. International Journal of MS Care 17:1, pages 35-41.
Crossref
Crossref
Evanthia Bernitsas, Fen Bao, Navid Seraji-Bozorgzad, Jessica Chorostecki, Carla Santiago, Alexandros Tselis, Christina Caon, Imad Zak, Scott Millis & Omar Khan. (2015) Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes. Multiple Sclerosis and Related Disorders 4:1, pages 47-51.
Crossref
Crossref
Sofia Straudi, Carlotta Martinuzzi, Claudia Pavarelli, Amira Sabbagh Charabati, Maria Grazia Benedetti, Calogero Foti, Michela Bonato, Eleonora Zancato & Nino Basaglia. (2014) A task-oriented circuit training in multiple sclerosis: a feasibility study. BMC Neurology 14:1.
Crossref
Crossref
Andrew R. Blight, Herbert R. HenneyIIIIII & Ron Cohen. (2014) Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosis. Annals of the New York Academy of Sciences 1329:1, pages 33-44.
Crossref
Crossref
Brett W. Fling, Geetanjali Gera Dutta, Heather Schlueter, Michelle H. Cameron & Fay B. Horak. (2014) Associations between Proprioceptive Neural Pathway Structural Connectivity and Balance in People with Multiple Sclerosis. Frontiers in Human Neuroscience 8.
Crossref
Crossref
Abbey Downing, David Van Ryn, Anne Fecko, Christopher Aiken, Sean McGowan, Sarah Sawers, Thomas McInerny, Katie Moore, Louis Passariello & Helen Rogers. (2014) Effect of a 2-Week Trial of Functional Electrical Stimulation on Gait Function and Quality of Life in People with Multiple Sclerosis. International Journal of MS Care 16:3, pages 146-152.
Crossref
Crossref
Bernard M.J. Uitdehaag. 2014. Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders
393
404
.
Hiromi Kikuchi, Nobuhiro Mifune, Masaaki Niino, Jun-ichi Kira, Tatsuo Kohriyama, Kohei Ota, Masami Tanaka, Hirofumi Ochi, Shunya Nakane & Seiji Kikuchi. (2013) Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis. BMC Neurology 13:1.
Crossref
Crossref
Jennifer Freeman, Richard Walters, Wendy Ingram, Anita Slade, Jeremy Hobart & John Zajicek. (2013) Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Multiple Sclerosis Journal 19:12, pages 1632-1639.
Crossref
Crossref
Susan L. Kasser & Terry Rizzo. (2013) An exploratory study of fitness practitioner intentions toward exercise programming for individuals with multiple sclerosis. Disability and Health Journal 6:3, pages 188-194.
Crossref
Crossref
Robert Fraser, Dawn Ehde, Dagmar Amtmann, Aimee Verrall, Kurt L. Johnson, Erica Johnson & George H. Kraft. (2013) Self-Management for People with Multiple Sclerosis. International Journal of MS Care 15:2, pages 99-106.
Crossref
Crossref
Victor W. Mark, Edward Taub, Gitendra Uswatte, Khurram Bashir, Gary R. Cutter, Camille C. Bryson, Staci Bishop-McKay & Mary H. Bowman. (2013) Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series With 4-Year Follow-Up. Archives of Physical Medicine and Rehabilitation 94:4, pages 753-760.
Crossref
Crossref
Diego Cadavid, Stephanie Jurgensen & Sophia Lee. (2013) Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis. PLoS ONE 8:1, pages e53297.
Crossref
Crossref
Andrew D. Goodman & Robert Thompson Stone. (2012) Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy). Neurotherapeutics 10:1, pages 106-110.
Crossref
Crossref
James Pike, Edward Jones, Krithika Rajagopalan, James Piercy & Peter Anderson. (2012) Social and economic burden of walking and mobility problems in multiple sclerosis. BMC Neurology 12:1.
Crossref
Crossref
M. Yildiz. (2012) The impact of slower walking speed on activities of daily living in patients with multiple sclerosis. International Journal of Clinical Practice 66:11, pages 1088-1094.
Crossref
Crossref
Marie Kierkegaard, Ulrika Einarsson, Kristina Gottberg, Lena von Koch & Lotta Widén Holmqvist. (2011) The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis. Multiple Sclerosis Journal 18:5, pages 639-646.
Crossref
Crossref
Vanessa L. D'Orio, Frederick W. Foley, Francine Armentano, Mary Ann Picone, Sonya Kim & Roee Holtzer. (2012) Cognitive and motor functioning in patients with multiple sclerosis: Neuropsychological predictors of walking speed and falls. Journal of the Neurological Sciences 316:1-2, pages 42-46.
Crossref
Crossref
Bianca Weinstock-Guttman, Steven L. Galetta, Gavin Giovannoni, Eva Havrdova, Michael Hutchinson, Ludwig Kappos, Paul W. O’Connor, J. Theodore Phillips, Chris Polman, William H. Stuart, Frances Lynn & Christophe Hotermans. (2011) Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. Journal of Neurology 259:5, pages 898-905.
Crossref
Crossref
C. Donzé & J. De Sèze. (2012) Spasticité et vie quotidienne dans la sclérose en plaques. Revue Neurologique 168, pages S51-S56.
Crossref
Crossref
P Feys, D Gijbels, A Romberg, C Santoyo, B Gebara, B Maertens de Noordhout, K Knuts, F Béthoux, V de Groot, C Vaney & U Dalgas. (2011) Effect of time of day on walking capacity and self-reported fatigue in persons with multiple sclerosis: a multi-center trial. Multiple Sclerosis Journal 18:3, pages 351-357.
Crossref
Crossref
Huiying Yu & Thompson Sarkodie-Gyan. (2012) Towards a Methodology for the Differential Analysis in Human Locomotion: A Pilot Study on the Participation of Individuals with Multiple Sclerosis. Engineering 04:10, pages 20-26.
Crossref
Crossref
Michaela CoenenBirgit Basedow-Rajwich, Nicolaus König, Jürg Kesselring & Alarcos Cieza. (2011) Functioning and disability in multiple sclerosis from the patient perspective. Chronic Illness 7:4, pages 291-310.
Crossref
Crossref
Andreas A. Argyriou, Panagiotis Karanasios, Amalia A. Ifanti, Gregoris Iconomou, Konstantinos Assimakopoulos, Alexandra Makridou, Fotini Giannakopoulou & Nicolaos Makris. (2011) Quality of life and emotional burden of primary caregivers: a case–control study of multiple sclerosis patients in Greece. Quality of Life Research 20:10, pages 1663-1668.
Crossref
Crossref
Michaela Coenen, Alarcos Cieza, Jenny Freeman, Fary Khan, Deborah Miller, Andrea Weise & Jürg Kesselring. (2011) The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference. Journal of Neurology 258:8, pages 1477-1488.
Crossref
Crossref
Rosaria Sacco, Rita Bussman, Peter Oesch, Jürg Kesselring & Serafin Beer. (2010) Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial. Journal of Neurology 258:5, pages 889-894.
Crossref
Crossref
Francois Bethoux & Susan Bennett. (2011) Evaluating Walking in Patients with Multiple Sclerosis. International Journal of MS Care 13:1, pages 4-14.
Crossref
Crossref
L. Rached, B. Lacour & M. Daudon. (2011) Lithiase urinaire et sclérose en plaques. Progrès en Urologie 21:2, pages 102-108.
Crossref
Crossref
Yára Dadalti Fragoso, Alessandro Finkelsztejn, Maria Cristina B. Giacomo, Liliana Russo & Wesley Soares Cruz. (2010) The effect of multiple sclerosis on the professional life of a group of Brazilian patients. Arquivos de Neuro-Psiquiatria 68:6, pages 914-917.
Crossref
Crossref